Cardioprotection of mAb2G4/ODN/lip on Myocardial Ischemia-Reperfusion Injury via Inhibiting the NF-κB Signaling Pathway

Figure 1

The experimental protocol in vivo. LADO: left anterior descending coronary artery occlusion; I/R myocardial ischemia-reperfusion; ODN/lip: liposome-NF-κB decoy oligodeoxynucleotide complexes; mAb2G4-ODN-lip: monoclonal anti-myosin antibody 2G4-attached cationic liposome-NF-κB decoy oligodeoxynucleotide complexes. All animals were sacrificed in the end of the experiment.